71
Volume 80, Number 1, January 1991
information to allow them to make an informed decision. We are not alone in our concern about the long-term eff...
information to allow them to make an informed decision. We are not alone in our concern about the long-term effects of the current vaccination schedules. A recent literature search carried out to update our leaflet revealed the continued dearth of studies comparing the morbidity and mortality in vaccinated and non-vaccinated populations over significant periods of time. FELICITY LEE MSC MRPHARMSRSHOM Chairperson
potency to patients who had similar symptoms. Double blind method was not possible with the fruit, but with potency proving it was possible. The editor of a good journal should be careful what he reports. PRAKASH VAKIL
1 M M R vaccine officially launched Pharmaceutical Journal 1988; 245: 469. 2 USA Centres for Disease Control Measles--United States, first 26 weeks, 1989. Journal of the American Medical Association 1990; 263: 497-501.
Surrealistic conference report S I R - - I must congratulate you on writing a 'surrealistic conference report' without attending the Barcelona Conference properly. You were not present when I presented my papers on 1 Proving criteria and experience (discussing Musa sapientium--banana proving) 2 Ageing process and homoeopthy I presented the two papers one after the other and showed a number of slides and a videorecording which you unfortunately missed. You walked in when Dr Schwabe was presenting his paper. You are not aware of the fact that Dr Hari Singh never attended the Conference and so never presented his paper. You have picked it up from the programme and the copy of the Transactions which you must have received. For your information, 70 persons were involved in the proving. Provers took bananas for 189to 2 months. One prover was found to be allergic to banana and produced severe symptoms, so she was advised to discontinue. Proving was also carried out with 6x and 30x potencies. Musa sapientium was also administered in
Animal experimentation SIR--The two lucid and forthright letters (M.C.H. Tennant-Blakeway and Geraldine R. Lindley) in the October issue justify support. Animal experimentation using homoeopathic preparations may well be valuable in veterinary hom0eopathy, but has little, if any, relevance to human medication. All information thus gained is purely academic and does not in any way advance the understanding of the materia medica and its application in human disease. Such articles should appear in veterinary publications, albeit under the aegis of the Faculty, but should not form part of the British Homoeopathic Journal in my opinion. Does their appearance in this journal indicate that the Faculty is becoming ambivalent in its attitude towards upholding the previously high standards of hom0eopathy? I sincerely hope not. One of the strengths of homoeopathy has been the proving of medicines on healthy human volunteers who are not taking any medication. On this has been built the materia medica. Are we to throw all the painstaking work of the last 200 years to the four winds, in order to be of a like mind with the conventional medical establishment in this matter? Heaven forbid. DAVID JOHNSON